<bill session="115" type="h" number="3348" updated="2017-08-02T19:00:14Z">
  <state datetime="2017-07-20">REFERRED</state>
  <status>
    <introduced datetime="2017-07-20"/>
  </status>
  <introduced datetime="2017-07-20"/>
  <titles>
    <title type="short" as="introduced">Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act</title>
    <title type="short" as="introduced">Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act</title>
    <title type="official" as="introduced">To expand the tropical disease product priority review voucher program to encourage treatments for the Middle East respiratory syndrome.</title>
    <title type="display">Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act</title>
  </titles>
  <sponsor id="412523"/>
  <cosponsors>
    <cosponsor id="412652" joined="2017-07-20"/>
    <cosponsor id="412704" joined="2017-07-20"/>
    <cosponsor id="412570" joined="2017-07-20"/>
  </cosponsors>
  <actions>
    <action datetime="2017-07-20">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-07-20" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects/>
  <amendments/>
  <committee-reports/>
</bill>
